Aemetis reported Q2 2023 revenues of $45.1 million, with a net loss of $25.3 million. The India Biodiesel segment contributed $33.6 million in sales. The Keyes plant restarted in late May after maintenance and efficiency upgrades.
Revenues for the second quarter of 2023 were $45.1 million, including $33.6 million from India Biodiesel sales.
Gross profit for the second quarter of 2023 was $2.0 million, an improvement compared to a $0.2 million gross loss in Q2 2022.
Net loss for the second quarter of 2023 was $25.3 million, compared to a net loss of $209 thousand for the second quarter of 2022.
India plant contributed $5.3 million of Adjusted EBITDA during the three months ended June 30, 2023, offset by Adjusted EBITDA from the restart of the Keyes plant and other operations, for a total company negative Adjusted EBITDA of $4.3 million.
This news release contains forward-looking statements, including statements regarding our assumptions, projections, expectations, targets, intentions or beliefs about future events or other statements that are not historical facts.
Analyze how earnings announcements historically affect stock price performance